SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-20-000614
Filing Date
2020-02-28
Accepted
2020-02-28 08:33:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da109488032_02272020.htm SC 13D/A 251840
2 COOPERATION AGREEMENT ex991to13da109488032_022720.htm EX-99.1 92501
  Complete submission text file 0000921895-20-000614.txt   346135
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43256 | Film No.: 20665763
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1370 BROADWAY 5TH FLOOR NEW YORK NY 10018
Business Address 1370 BROADWAY 5TH FLOOR NEW YORK NY 10018 (212) 321-0048
ENGINE CAPITAL, L.P. (Filed by) CIK: 0001580320 (see all company filings)

IRS No.: 364755478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A